Novo Nordisk Launches Once-Weekly Basal Insulin 'Awiqli' in India as Diabetes Rates Increase

World’s first once-weekly insulin injection launched in India: Endocrinologist shares 7 things to know before switching

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side effects, and dosage. 

Novo Nordisk insulin pen price in India: How much will once-weekly Awiqli cost you? Check its variants

Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to weekly. In a statement, it said that more than 101 million people in India are living with diabetes, while an additional 136 million have prediabetes.

Novo Nordisk launches once-weekly insulin shot in India at Rs 261 a week, aims to help more diabetics switch

The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among people with diabetes.

India gets world's first once-a-week insulin: All about Novo Nordisk's Awiqli

India News: India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin approved for clinical use, o.

Novo Nordisk launches world's first once-weekly basal insulin in India

In the ONWARDS-1 clinical programme, Awiqli; demonstrated superior HbA1c reduction and increased Time in Range compared with once-daily glargine U100. More people with Type 2 diabetes achieved an HbA1c level below 7% without hypoglycaemia, while the significant improvement in Time in Range provided patients with better glucose control throughout the day.